194 related articles for article (PubMed ID: 19941066)
1. Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after D-kynurenine infusion: an in vivo microdialysis study.
Ogaya T; Song Z; Ishii K; Fukushima T
Neurochem Res; 2010 Apr; 35(4):559-63. PubMed ID: 19941066
[TBL] [Abstract][Full Text] [Related]
2. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.
Fukushima T; Sone Y; Mitsuhashi S; Tomiya M; Toyo'oka T
Chirality; 2009 Apr; 21(4):468-72. PubMed ID: 18655158
[TBL] [Abstract][Full Text] [Related]
3. Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.
Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
Neuroscience; 2010 Sep; 169(4):1848-59. PubMed ID: 20600676
[TBL] [Abstract][Full Text] [Related]
4. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
[TBL] [Abstract][Full Text] [Related]
5. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of D-amino acid oxidase activity in rat kidney using a D-kynurenine derivative, 6-methylthio-D-kynurenine: An in vivo microdialysis study.
Fukushima T; Kansaku A; Umino M; Sakamoto T; Onozato M
Drug Discov Ther; 2024 Jan; 17(6):434-439. PubMed ID: 38044118
[TBL] [Abstract][Full Text] [Related]
7. Alternative kynurenic acid synthesis routes studied in the rat cerebellum.
Blanco Ayala T; Lugo Huitrón R; Carmona Aparicio L; Ramírez Ortega D; González Esquivel D; Pedraza Chaverrí J; Pérez de la Cruz G; Ríos C; Schwarcz R; Pérez de la Cruz V
Front Cell Neurosci; 2015; 9():178. PubMed ID: 26041992
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
Bortz DM; Wu HQ; Schwarcz R; Bruno JP
Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on kynurenic acid production in the rat striatum by tryptophan enantiomers: an in vivo microdialysis study.
Ishii K; Iizuka H; Ogaya T; Song Z; Fukushima T
Chirality; 2011; 23 Suppl 1():E12-5. PubMed ID: 21433090
[TBL] [Abstract][Full Text] [Related]
11. Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers.
Ishii K; Ogaya T; Song Z; Iizuka H; Fukushima T
Chirality; 2010 Nov; 22(10):901-6. PubMed ID: 20872665
[TBL] [Abstract][Full Text] [Related]
12. Probenecid Increases the Concentration of 7-Chlorokynurenic Acid Derived from the Prodrug 4-Chlorokynurenine within the Prefrontal Cortex.
Patel W; Rimmer L; Smith M; Moss L; Smith MA; Snodgrass HR; Pirmohamed M; Alfirevic A; Dickens D
Mol Pharm; 2021 Jan; 18(1):113-123. PubMed ID: 33307708
[TBL] [Abstract][Full Text] [Related]
13. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
[TBL] [Abstract][Full Text] [Related]
14. Fluorimetric assay for D-amino acid oxidase activity in rat brain homogenate by using D-kynurenine as a substrate.
Kozaki A; Iwasa S; Hosoda S; Nishiguchi Y; Nakayama M; Ichiba H; Fukushima T
Biosci Trends; 2012 Oct; 6(5):241-7. PubMed ID: 23229117
[TBL] [Abstract][Full Text] [Related]
15. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.
Ceresoli-Borroni G; Rassoulpour A; Wu HQ; Guidetti P; Schwarcz R
J Neural Transm (Vienna); 2006 Oct; 113(10):1355-65. PubMed ID: 16465454
[TBL] [Abstract][Full Text] [Related]
16. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
18. Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.
Pocivavsek A; Wu HQ; Elmer GI; Bruno JP; Schwarcz R
Eur J Neurosci; 2012 May; 35(10):1605-12. PubMed ID: 22515201
[TBL] [Abstract][Full Text] [Related]
19. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
[TBL] [Abstract][Full Text] [Related]
20. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
